Meet Us at AHA 2021

SCIRENT is exhibitor at the American Heart Association 2021 Scientific Sessions.

10.11.2021. SCIRENT is attending the American Heart Association’s Scientific Sessions, AHA 2021, from November 13-15, 2021 as a proud exhibitor. Visit our booth and connect with us live to learn more about our industry-leading cardiovascular research services, patient recruitment capabilities, and study experience. The American Heart Association’s Scientific Sessions 2021 is the largest cardiovascular meeting […]

SCIRENT Appoints Dr. Maximilian Posch, MD, as Chief Medical Officer

BERLIN, Sept. 21, 2021 /PRNewswire/ — SCIRENT, an international full-service cardiovascular contract research organization (CRO), is proud to appoint Dr. Maximilian Posch as Chief Medical Officer. In his new position, Dr. Posch will be an important driver of SCIRENT’s growth by contributing medical and scientific expertise to support SCIRENT’s service portfolio and consulting clients on […]

Restarting by Design: Agile Crisis Management for Rapid Resumption of Cardiovascular Clinical Trials

Crisis Management for Rapid Resumption of Cardiovascular Clinical Trials during the COVID-19 pandemic

The entire landscape of hospital-based clinical trials dramatically changed when COVID-19 singlehandedly stopped the global recruitment of ongoing cardiovascular trials. Heart failure clinical trials were already subject to factors such as regional variation in clinical practice, trial implementation, and patient characteristics, which drive event rate and treatment effect size assumptions key to demonstrating clinical benefit. […]

SCIRENT and Virtonomy Announce Joint Efforts to Advance Use of Virtual Patients in Medical Device Clinical Trials

SCIRENT Virtual Core Lab

SCIRENT, a full-service contract research organization (CRO) specialized in cardiovascular trials, and Virtonomy, a pioneer in developing data-driven clinical trials using virtual patients, announced today their cooperation on the use of virtual patients in medical device clinical trials. Both companies offer services for the development of medical devices. By working together, valuable time and financial resources […]